Back
Quince Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
16
QNCX
Quince Therapeutics, Inc.
Last Price:
$0.10
Seasonality Move:
-1.12%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and QNCX is experiencing selling pressure, which indicates risk of future bearish movement.
Quince Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.15 | Sell |
| 20-day SMA: | 0.2 | Sell |
| 50-day SMA: | 1.96 | Sell |
| 200-day SMA: | 1.83 | Sell |
| 8-day EMA: | 0.12 | Buy |
| 20-day EMA: | 0.08 | Buy |
| 50-day EMA: | 0.04 | Buy |
| 200-day EMA: | 0.01 | Buy |
Quince Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.04 | Buy |
| Relative Strength Index (14 RSI): | 27.66 | Sell |
| Chaikin Money Flow: | 12209441 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Quince Therapeutics, Inc. Technical Analysis
| Feb 17 | Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | ||||||||||
| 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Quince Therapeutics, Inc. Stock
Is Quince Therapeutics, Inc. Stock a Buy?
-
Quince Therapeutics, Inc. share price is 0.13 while QNCX 8-day simple moving average is 0.15, which is a Sell signal.
-
The stock price of QNCX is 0.13 while Quince Therapeutics, Inc. 20-day SMA is 0.20, which makes it a Sell.
-
Quince Therapeutics, Inc. 50-day simple moving average is 1.96 while QNCX share price is 0.13, making it a Sell technically.
-
QNCX stock price is 0.13 and Quince Therapeutics, Inc. 200-day simple moving average is 1.83, creating a Sell signal.
QNCX Technical Analysis vs Fundamental Analysis
Sell
16
Quince Therapeutics, Inc. (QNCX)
is a Sell
Is Quince Therapeutics, Inc. a Buy or a Sell?
-
Quince Therapeutics, Inc. stock is rated a SellThe current Quince Therapeutics, Inc. [QNCX] share price is $0.13. The Score for QNCX is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.
Quince Therapeutics, Inc. Stock Info
Market Cap:
7M
Price in USD:
0.13
Share Volume:
26.9M
Quince Therapeutics, Inc. 52-Week Range
52-Week High:
4.55
52-Week Low:
0.10
Sell
16
Quince Therapeutics, Inc. (QNCX)
is a Sell
Quince Therapeutics, Inc. Share Price Forecast
-
What is the Quince Therapeutics, Inc. stock price today?The Quince Therapeutics, Inc. stock price is 0.13 USD today.
-
Will QNCX stock go up or go down?Quince Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Quince Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Quince Therapeutics, Inc. is overvalued.
Is Quince Therapeutics, Inc. Stock a Buy?
-
Quince Therapeutics, Inc. share price is 0.13 while QNCX 8-day exponential moving average is 0.12, which is a Buy signal.
-
The stock price of QNCX is 0.13 while Quince Therapeutics, Inc. 20-day EMA is 0.08, which makes it a Buy.
-
Quince Therapeutics, Inc. 50-day exponential moving average is 0.04 while QNCX share price is 0.13, making it a Buy technically.
-
QNCX stock price is 0.13 and Quince Therapeutics, Inc. 200-day simple moving average is 0.01, creating a Buy signal.
Fundamental Analysis of Quince Therapeutics, Inc.
Is Quince Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.27 per share.
Technical Analysis of Quince Therapeutics, Inc.
Should I short Quince Therapeutics, Inc. stock?
-
QNCX Moving Average Covergence Divergence (MACD) indicator is 0.04, suggesting Quince Therapeutics, Inc. is a Buy
-
Quince Therapeutics, Inc. Relative Strength Index (RSI) is 27.66, which suggest Quince Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Quince Therapeutics, Inc. is ( - ), which suggest Quince Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Quince Therapeutics, Inc. is ( - ), which suggest Quince Therapeutics, Inc. is a Buy
* Quince Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.